Table 3 TCGA lung adenocarcinoma patient characteristics
Clinical characteristics | Total (502) | Percentage (%) |
|---|---|---|
Gender | ||
 Male | 232 | 46.2% |
 Female | 270 | 53.8% |
Age | ||
 < =70 years old | 330 | 65.7% |
 > 70 years old | 162 | 32.3% |
 Missing | 10 | 2.0% |
Number pack years smoked | ||
 < =40 | 362 | 72.1% |
 > 40 | 140 | 27.9% |
EGFR mutation status | ||
 Yes | 81 | 16.1% |
 No | 191 | 38.0% |
 Missing | 230 | 45.9% |
KRAS mutation status | ||
 Yes | 63 | 12.5% |
 No | 245 | 48.8% |
 Missing | 194 | 38.7% |
ALK mutation status | ||
 Yes | 35 | 7.0% |
 No | 207 | 41.2% |
 Missing | 260 | 51.8% |
T stage | ||
 T1 | 168 | 33.5% |
 T2 | 268 | 53.4% |
 T3 | 45 | 9.0% |
 T4 | 18 | 3.6% |
 Missing | 3 | 0.6% |
N stage | ||
 N0 | 326 | 64.9% |
 N1 | 94 | 18.7% |
 N2 | 69 | 13.7% |
 N3 | 2 | 0.4% |
 Missing | 11 | 2.2% |
M stage | ||
 M0 | 333 | 66.3% |
 M1 | 24 | 4.8% |
 Missing | 145 | 28.9% |
TNM stage | ||
 Stage I | 270 | 53.8% |
 Stage II | 119 | 23.7% |
 Stage III | 80 | 15.9% |
 Stage IV | 25 | 5.0% |
 Missing | 8 | 1.6% |
CANT1 expression | ||
 Low | 210 | 41.8% |
 High | 292 | 58.2% |
Vital status | ||
 Dead | 182 | 36.3% |
 Alive | 320 | 63.7% |